This blog explores how the fixed-dose combination of Pantoprazole 40 mg + Domperidone 10 mg delivers a dual-action advantage in GERD and acid-related disorders. By combining Pantoprazole’s powerful acid suppression with Domperidone’s prokinetic action, it ensures faster relief, improved gastric motility, and long-lasting patient comfort. The article highlights its clinical superiority over monotherapy, regulatory acceptance, and formulation excellence by Walter Healthcare, ma

Explore high-impact opportunities as branded and blockbuster drugs lose patent protection in India between 2025-2027. Gain insights into...